Stay updated on ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page
- Check2 days agoChange DetectedThe study's revision history now shows Revision: v3.5.4 replacing Revision: v3.5.3, indicating an administrative update to the record. This change does not alter the study data, eligibility, or results.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe Record History now shows a new version tag (Revision: v3.5.3) replacing the previous v3.5.2. This indicates an update to the page history metadata rather than changes to the study content.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the page history.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 in the page footer.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision v3.4.3 was added to the history and revision v3.4.2 was removed.SummaryDifference0.0%

- Check95 days agoChange DetectedAdded a new Revision: v3.4.2 to the record history. The government-funding notice and the prior Revision: v3.4.1 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page.